时 间：2024年3月20日（周三）下午15:00

地 点：阜成路校区东区1号楼一层127会议室

报告内容：生物大分子在医疗应用方面具有巨大的潜力。和传统的小分子药物相比较，生物大分子药物具有高分子量，高带电性和高敏感性结构。因此，实现有效地靶向递送给药，是其面临的巨大挑战之一。该讲座旨在介绍仿生纳米制剂如何解决这些问题，以达到有效治疗疾病的目的。

报告人介绍：陈荣军 博士 英国伦敦帝国理工学院 化学工程系 教授

Professor Rongjun Chen obtained his PhD degree and did his postdoctoral work in the Department of Chemical Engineering and Biotechnology at the University of Cambridge. He is currently Professor of Biomaterials Engineering and Head of the Biomaterials and Nanomedicine Laboratory in the Department of Chemical Engineering at Imperial College London. His research focuses on design, synthesis and manufacturing of polymers, lipids and bio-inspired nanoparticles for targeted delivery of active pharmaceutical agents through fundamental understanding of their transport processes across extracellular and intracellular barriers. He has developed a translational research programme on targeted nanomedicine, thermostable vaccine formulation, cell and gene therapy. His research has been recognised by various awards including the IChemE Global Team Award in 2021, Imperial College President’s Award for Outstanding Research Team in 2021, and highly commended for IChemE Global Biotechnology Award in 2018. He is an Editor for Chemical Engineering Journal (Elsevier) and an Editorial Board Member of Discover Molecules (Springer Nature).